4th Global Conference on Biotech, Bioengineering & Biomedical Engineering

The 4th edition of the Global Conference on Biotechnology, Bioengineering, and Biomedical Engineering in Honolulu, USA, explores aspects of biotechnology, bioengineering, and biomedical engineering. Participants will walk through biotechnology evolution, explore complex topics in biomedical engineering, and engage with ethical dilemmas in the field.

This conference highlights breakthroughs in CRISPR technology, synthetic biology, and stem cell research in the biotechnology segment. Plus, bioengineering sessions will dive into tissue engineering and 3D bioprinting. Meanwhile, biomedical engineering will focus on new developments in medical imaging and wearable health technologies.

The 4th Global Conference on Biotechnology, Bioengineering, and Biomedical Engineering serves as a crucial gathering for pioneers in biotechnology, bioengineering, and biomedical engineering from around the globe. It offers a platform to showcase advanced innovations from genomic editing to advanced medical imaging technologies, combining historical perspectives with futuristic explorations.

• Registration Deadline: December 27, 2024
• Conference Date: January 11, 2025

Program Schedule :

• Friday, January 10, 2025 – Arrival & Reception of the participants in Honolulu, USA
• Saturday, January 11, 2025 (Conference Day) – Registration, opening speech, keynote speech, and technical sessions
• Sunday, January 12, 2025 – City visit (optional to the participants)

Terms & Conditions :

• Please note that all registration fees are non-refundable, non-negotiable, and non-transferable.
• Please make your own arrangements for visa (if applicable), accommodation, meals, and transportation during the conference.
• After completing the registration and verifying your successful payment, a regular invitation letter will be sent within 3 business days.

Changes due to spelling or minor mistakes in the invitation letter will cost US$50.

Host or Publisher Global Conference Alliance Inc.